TXNDC5 and nonpapillary renal cell carcinoma: Our study is the first to show differential expression of ERp46 in human ccRCC and to demonstrate an effect of ERp46 expression on in vivo tumorigenesis potentially through increased angiogenesis (Figure 2df), a hallmark of ccRCC pathogenesis [24].